Anti-E1E2 Antibodies (D32.10 Epitope-binding Antibodies) and HCV Triple Therapy
NCT02877199
·
clinicaltrials.gov ↗
COMPLETED
Status
19
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis C
Interventions
OTHER:
Triple therapy
Sponsor
Hospices Civils de Lyon